The purpose of this study is to establish the safety and efficacy of ketotifen/naphazoline ophthalmic solution compared to vehicle and its individual components in alleviating the signs and symptoms of conjunctival allergen challenge (CAC)-induced allergic conjunctivitis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Ocular Itching
Timeframe: 3, 5, and 7 minutes post challenge at 14 days
Conjunctival Redness
Timeframe: 7, 15, and 20 minutes post challenge at 14 days